AnMed Achieves 14.6X ROI with Xsolis AI Utilization Management
Event summary
- AnMed realized a 14.6X ROI from June 2024 to June 2025 using Xsolis' AI-powered Dragonfly™ platform.
- The health system saved 1,221 hours in front-end review time through Xsolis’ Precision UM program with a national health plan.
- AnMed expanded its use of Xsolis beyond initial adoption to include shared clinical access and physician advisory services.
- Utilization management remains a significant source of administrative burden, accounting for nearly 25% of U.S. healthcare spending.
The big picture
AnMed’s results highlight the growing need for AI-driven solutions to reduce administrative waste in healthcare. As value-based care models expand, providers and payers are increasingly seeking collaborative tools that streamline decision-making and improve patient outcomes. The success of Xsolis’ platform suggests a potential shift toward more data-driven, objective clinical assessments across the industry.
What we're watching
- Scalability of AI Solutions
- Whether Xsolis can replicate AnMed’s success with other health systems under similar administrative pressures.
- Payer Collaboration
- The pace at which more health plans adopt shared clinical data approaches for utilization management.
- Regulatory Impact
- How evolving healthcare regulations may affect AI-driven utilization management and payer-provider collaboration.
Related topics